Literature DB >> 33296528

Decision making and framing effects in multiple sclerosis.

Laura Zamarian1, Thomas Berger1,2, Marie-Theres Pertl1, Gabriel Bsteh1,2, Atbin Djamshidian1, Florian Deisenhammer1, Margarete Delazer1.   

Abstract

BACKGROUND: Previous studies reported reduced decision-making abilities for patients with multiple sclerosis (MS) relative to healthy controls (HC). This study aimed to evaluate whether these problems arise when sampling information or when pondering about the evidence collected.
METHODS: In a cross-sectional, controlled study, 43 relapsing-remitting MS patients (RRMS; Expanded Disability Status Scale 1.5, range 0-4) and 53 HC performed an information sampling task ('beads task'), a health-related framing task, and neuropsychological background tests.
RESULTS: In the beads task, patients collected as much information as HC prior to a decision. However, there were twice as many patients as HC making irrational decisions, that is, decisions against the evidence collected (RRMS: 26/43, 60%; HC: 16/53, 30%; p = 0.003). Compared to HC, patients also showed a stronger framing effect, that is, they were more strongly biased by the way health-related information was presented (p < 0.05, Cohen's d = 0.5). Overall, the framing effect predicted whether a participant would make irrational decisions (OR 2.12, 95% CI 1.29-3.49, p < 0.001).
CONCLUSIONS: Predecisional information sampling is intact in RRMS. However, compared to HC, patients are more likely to make irrational decisions and to be biased by the way health-related information is framed. This warrants caution in communication, especially in the medical context, with patients.
© 2020 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Entities:  

Keywords:  executive functions; logistic models; neuropsychological tests; relapsing-remitting; risk taking

Year:  2020        PMID: 33296528     DOI: 10.1111/ene.14669

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  1 in total

Review 1.  [The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 1: recommendations].

Authors:  Tobias Monschein; Tobias Zrzavy; Micha Löbermann; Alexander Winkelmann; Thomas Berger; Paulus Rommer; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nervenarzt       Date:  2021-07-07       Impact factor: 1.297

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.